Literature DB >> 20569803

Contemporary surgical management of pediatric urolithiasis.

Marc C Smaldone1, Steven G Docimo, Michael C Ost.   

Abstract

With miniaturization of instruments and refinement of surgical technique, the management of pediatric stone disease has undergone a dramatic evolution. While shock wave lithotripsy (SWL) is still commonly used to treat upper tract calculi, the use of ureteroscopy (URS) has dramatically increased and is now the procedure of choice for upper tract stone burdens less than 1.5cm at centers with significant experience. Percutaneous nephrolithotomy (PCNL) has replaced open surgical techniques for the treatment of large stone burdens greater than 2cm, with efficacy and complication rates similar to the adult population. Large institutional series demonstrate comparable stone-free and complication rates with SWL, URS, and PCNL, but concerns remain with these techniques regarding renal development and damage to the pediatric urinary tract. Randomized controlled trials comparing the efficacy of SWL and URS for upper tract stone burdens are needed to reach consensus regarding the most effective primary treatment modality in children.

Entities:  

Mesh:

Year:  2010        PMID: 20569803     DOI: 10.1016/j.ucl.2010.03.006

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  18 in total

1.  Percutaneous nephrolithotomy of bilateral staghorn renal calculi in pediatric patients: 12 years experience in a tertiary care centre.

Authors:  Bimalesh Purkait; Manoj Kumar; Ashok Kumar Sokhal; Ankur Bansal; Satya Narayan Sankhwar; Ashok Kumar Gupta
Journal:  Urolithiasis       Date:  2016-09-15       Impact factor: 3.436

2.  Management of stone disease in infants.

Authors:  Mujdem Nur Azili; Fatma Ozturk; Mihriban Inozu; Fatma Şemsa Çayci; Banu Acar; Sengul Ozmert; Tugrul Tiryaki
Journal:  Urolithiasis       Date:  2015-06-03       Impact factor: 3.436

Review 3.  Effect of urinary stone disease and its treatment on renal function.

Authors:  Ozden Ender; Necmettin Mercimek Mehmet
Journal:  World J Nephrol       Date:  2015-05-06

Review 4.  Percutaneous nephrolithotomy in pediatric age group: Assessment of effectiveness and complications.

Authors:  Ender Ozden; Mehmet Necmettin Mercimek
Journal:  World J Nephrol       Date:  2016-01-06

5.  Percutaneous endoscopic treatment for urinary stones in pediatric patients: where we are now.

Authors:  Paolo Caione; Giuseppe Collura; Michele Innocenzi; Mauro De Dominicis; Simona Gerocarni Nappo; Nicola Capozza
Journal:  Transl Pediatr       Date:  2016-10

6.  Is mini-percutaneous nephrolithotomy a safe alternative to extracorporeal shockwave lithotripsy in pediatric age group in borderline stones? a randomized prospective study.

Authors:  Ahmed Farouk; Ahmed Tawfick; Mohamed Shoeb; Mahmoud A Mahmoud; Diaa Eldin Mostafa; Mohamed Hasan; Hany M Abdalla
Journal:  World J Urol       Date:  2018-02-15       Impact factor: 4.226

7.  Treatment of upper urinary tract stones with flexible ureteroscopy in children.

Authors:  Jing Xiao; Xiangyu Wang; Jun Li; Miaoiao Wang; Tiandong Han; Caixiang Zhang; Yuan Du; Gangyue Hao; Ye Tian
Journal:  Can Urol Assoc J       Date:  2018-08-30       Impact factor: 1.862

8.  Comparison of children versus adults undergoing mini-percutaneous nephrolithotomy: large-scale analysis of a single institution.

Authors:  Guohua Zeng; Zhijian Zhao; ShawPong Wan; Wen Zhong; Wenqi Wu
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

9.  Patient and stone characteristics associated with surgical intervention in pediatrics.

Authors:  Esther Jun; Peter Metcalfe; Piush J Mandhane; R Todd Alexander
Journal:  Can J Kidney Health Dis       Date:  2015-06-02

10.  Comparison of outcomes of tubed versus tubeless percutaneous nephrolithotomy in children: A single center study.

Authors:  Nadeem Iqbal; Salman Assad; Ijaz Hussain; Yumna Hassan; Hafsa Khan; Muhammad Armaghan Farooq; Saeed Akhter
Journal:  Turk J Urol       Date:  2018-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.